Dr. Reddy's Laboratories

RDY

19 Obserwujący

$13.17

-2.59%

-$0.35

Obserwuj

N/A

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

RDY Fair Price

$9.98

Overvalued by 08.6%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

My Notes

Začít psát

Profile

Dr. Reddy's Laboratories Limited (RDY) is an Indian pharmaceutical company specializing in the manufacturing and distribution of a wide range of medicines and generic pharmaceutical products. The company focuses on developing and producing high-quality and affordable medications for patients worldwide. Dr. Reddy's Laboratories has an extensive portfolio of products, including medicines for various therapeutic areas, such as cardiovascular, gastrointestinal, oncology, neurological, and other indications. The company is one of the leading generic pharmaceutical companies and has a strong global presence. Dr. Reddy's Laboratories invests in research and development of new pharmaceutical products and continuously expands its portfolio. Its medications comply with strict quality standards and regulations, making it a trustworthy partner for healthcare institutions, physicians, and patients. Investing in shares of Dr. Reddy's Laboratories Limited (RDY) could present an intriguing opportunity for those who believe in the growing demand for affordable and high-quality generic medicines and the long-term potential of the pharmaceutical industry.

Feed

There are no posts to show right now.